Literature DB >> 20404271

The absence of serum IgM enhances the susceptibility of mice to pulmonary challenge with Cryptococcus neoformans.

Krishanthi S Subramaniam1, Kausik Datta, Eric Quintero, Catherine Manix, Matthew S Marks, Liise-Anne Pirofski.   

Abstract

The importance of T cell-mediated immunity for resistance to the disease (cryptococcal disease) caused by Cryptococcus neoformans is incontrovertible, but whether Ab immunity also contributes to resistance remains uncertain. To investigate the role of IgM in resistance to C. neoformans, we compared the survival, fungal burden, lung and brain inflammatory responses, and lung phagocytic response of sIgM(-/-) mice, which lack secreted IgM, to that of IgM sufficient C57BL6x129Sv (heretofore, control) mice at different times after intranasal infection with C. neoformans (24067). sIgM(-/-) mice had higher mortality and higher blood and brain CFUs 28 d postinfection, but lung CFUs were comparable. Lungs of control mice manifested exuberant histiocytic inflammation with visible C. neoformans, findings that were not observed in sIgM(-/-) mice, whereas in brain sections, sIgM(-/-) mice had marked inflammation with visible C. neoformans that was not observed in control mice. Cytokine responses were significant for higher levels of lung IL-1beta and IL-12 24 h postinfection in control mice and higher levels of lung and brain IL-17 28 d postinfection in sIgM(-/-) mice. Alveolar macrophage phagocytosis was significantly higher for control than for sIgM(-/-) mice 24 h postinfection; however, phagocytic indices of sIgM(-/-) mice increased after reconstitution of sIgM(-/-) mice with polyclonal IgM. These data establish a previously unrecognized role for IgM in resistance to intranasal infection with C. neoformans in mice and suggest that the mechanism by which it mediates a host benefit is by augmenting Th1 polarization, macrophage recruitment and phagocytosis of C. neoformans.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20404271      PMCID: PMC2885446          DOI: 10.4049/jimmunol.0901638

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  84 in total

1.  Cryptococcus neoformans variants generated by phenotypic switching differ in virulence through effects on macrophage activation.

Authors:  A Guerrero; N Jain; X Wang; B C Fries
Journal:  Infect Immun       Date:  2010-01-04       Impact factor: 3.441

2.  Early local generation of C5a initiates the elicitation of contact sensitivity by leading to early T cell recruitment.

Authors:  R F Tsuji; I Kawikova; R Ramabhadran; M Akahira-Azuma; D Taub; T E Hugli; C Gerard; P W Askenase
Journal:  J Immunol       Date:  2000-08-01       Impact factor: 5.422

3.  Molecular basis for immunoglobulin M specificity to epitopes in Cryptococcus neoformans polysaccharide that elicit protective and nonprotective antibodies.

Authors:  A Nakouzi; P Valadon; J Nosanchuk; N Green; A Casadevall
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

4.  Mouse B-1 cell-derived mononuclear phagocyte, a novel cellular component of acute non-specific inflammatory exudate.

Authors:  S R Almeida; L S Aroeira; E Frymuller; M A Dias; C S Bogsan; J D Lopes; M Mariano
Journal:  Int Immunol       Date:  2001-09       Impact factor: 4.823

5.  Immunoglobulin G monoclonal antibodies to Cryptococcus neoformans protect mice deficient in complement component C3.

Authors:  Scott Shapiro; David O Beenhouwer; Marta Feldmesser; Carlos Taborda; Michael C Carroll; Arturo Casadevall; Matthew D Scharff
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

6.  Antibody efficacy in murine pulmonary Cryptococcus neoformans infection: a role for nitric oxide.

Authors:  Johanna Rivera; Jean Mukherjee; Louis M Weiss; Arturo Casadevall
Journal:  J Immunol       Date:  2002-04-01       Impact factor: 5.422

7.  Antibody-mediated protection in murine Cryptococcus neoformans infection is associated with pleotrophic effects on cytokine and leukocyte responses.

Authors:  Marta Feldmesser; Aron Mednick; Arturo Casadevall
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

8.  Serologic evidence for Cryptococcus neoformans infection in early childhood.

Authors:  D L Goldman; H Khine; J Abadi; D J Lindenberg; R Niang; A Casadevall
Journal:  Pediatrics       Date:  2001-05       Impact factor: 7.124

9.  C5a alters blood-brain barrier integrity in experimental lupus.

Authors:  Alexander Jacob; Bradley Hack; Eddie Chiang; Joe G N Garcia; Richard J Quigg; Jessy J Alexander
Journal:  FASEB J       Date:  2010-01-11       Impact factor: 5.191

10.  B-1 and B-2 cell-derived immunoglobulin M antibodies are nonredundant components of the protective response to influenza virus infection.

Authors:  N Baumgarth; O C Herman; G C Jager; L E Brown; L A Herzenberg; J Chen
Journal:  J Exp Med       Date:  2000-07-17       Impact factor: 14.307

View more
  63 in total

Review 1.  Induction of protective immunity against cryptococcosis.

Authors:  Karen L Wozniak; Sarah Hardison; Michal Olszewski; Floyd L Wormley
Journal:  Mycopathologia       Date:  2011-12-06       Impact factor: 2.574

2.  Determining the phagocytic activity of clinical antibody samples.

Authors:  Elizabeth G McAndrew; Anne-Sophie Dugast; Anna F Licht; Justin R Eusebio; Galit Alter; Margaret E Ackerman
Journal:  J Vis Exp       Date:  2011-11-30       Impact factor: 1.355

Review 3.  Ten challenges on Cryptococcus and cryptococcosis.

Authors:  Maurizio Del Poeta; Arturo Casadevall
Journal:  Mycopathologia       Date:  2011-09-24       Impact factor: 2.574

Review 4.  The importance of natural IgM: scavenger, protector and regulator.

Authors:  Michael R Ehrenstein; Clare A Notley
Journal:  Nat Rev Immunol       Date:  2010-10-15       Impact factor: 53.106

5.  Antibody immunity and natural resistance to cryptococcosis.

Authors:  N Trevijano-Contador; L Pirofski
Journal:  Curr Trop Med Rep       Date:  2019-04-04

6.  Identification and characterization of Cryptococcus neoformans protein fractions that induce protective immune responses.

Authors:  Ashok K Chaturvedi; Susan T Weintraub; Jose L Lopez-Ribot; Floyd L Wormley
Journal:  Proteomics       Date:  2013-12       Impact factor: 3.984

7.  Human IgM Inhibits the Formation of Titan-Like Cells in Cryptococcus neoformans.

Authors:  Nuria Trevijano-Contador; Kaila M Pianalto; Connie B Nichols; Oscar Zaragoza; J Andrew Alspaugh; Liise-Anne Pirofski
Journal:  Infect Immun       Date:  2020-03-23       Impact factor: 3.441

8.  Immune Surveillance by Natural IgM Is Required for Early Neoantigen Recognition and Initiation of Adaptive Immunity.

Authors:  Shaikh M Atif; Sophie L Gibbings; Elizabeth F Redente; Faye A Camp; Raul M Torres; Ross M Kedl; Peter M Henson; Claudia V Jakubzick
Journal:  Am J Respir Cell Mol Biol       Date:  2018-11       Impact factor: 6.914

Review 9.  Protective autoantibodies in the rheumatic diseases: lessons for therapy.

Authors:  Gregg J Silverman; Jaya Vas; Caroline Grönwall
Journal:  Nat Rev Rheumatol       Date:  2013-03-19       Impact factor: 20.543

10.  FcμR in human B cell subsets in primary selective IgM deficiency, and regulation of FcμR and production of natural IgM antibodies by IGIV.

Authors:  Sudhir Gupta; Sudhanshu Agrawal; Sastry Gollapudi; Hiromi Kubagawa
Journal:  Hum Immunol       Date:  2016-10-14       Impact factor: 2.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.